Regeneron/Bayer Partnership Seeks To Build Upon Eylea's Success
This article was originally published in The Pink Sheet Daily
Executive Summary
Latest ophthalmologic collaboration between the partners seeks to create an Eylea successor by combining aflibercept with an Ang2 antibody.